Ovarian Cancer
Ovarian Borderline Tumors
GYOEDU Resident: Ovarian Cancer Part 3
HIPEC in ovarian cancer
Korean HIPEC trial
The addition of HIPEC after interval cytoreductive surgery following neoadjuvant chemotherapy provided significant improvements in PFS and OS.
Mucinous Ovarian Carcinoma
GOG 241: Phase III Randomized Trial in Patients with Mucinous Epithelial Ovarian Cancer
Neither oxaliplatin-capecitabine nor bevacizumab significantly improved OS or PFS compared to paclitaxel-carboplatin in advanced-stage mucinous ovarian cancer.